Cognex Corporation (CGNX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Cognex Corporation stock (CGNX) is currently trading at $51.61. Cognex Corporation PE ratio is 75.01. Cognex Corporation PS ratio (Price-to-Sales) is 8.57. Analyst consensus price target for CGNX is $65.50. WallStSmart rates CGNX as Sell.
- CGNX PE ratio analysis and historical PE chart
- CGNX PS ratio (Price-to-Sales) history and trend
- CGNX intrinsic value — DCF, Graham Number, EPV models
- CGNX stock price prediction 2025 2026 2027 2028 2029 2030
- CGNX fair value vs current price
- CGNX insider transactions and insider buying
- Is CGNX undervalued or overvalued?
- Cognex Corporation financial analysis — revenue, earnings, cash flow
- CGNX Piotroski F-Score and Altman Z-Score
- CGNX analyst price target and Smart Rating
Cognex Corporation
📊 No data available
Try selecting a different time range
CGNX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Cognex Corporation (CGNX)
CGNX trades 78% above its Graham fair value of $24.21, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Cognex Corporation (CGNX) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around return on equity and price/sales. Mixed signals suggest waiting for clearer direction before acting.
Cognex Corporation (CGNX) Key Strengths (2)
103.10% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Cognex Corporation (CGNX) Areas to Watch (8)
Very expensive at 8.6x annual revenue
Very expensive at 5.5x book value
Low profitability relative to shareholder equity
Paying a premium for growth, expensive relative to earnings expansion
Thin operating margins with cost pressures present
Modest revenue growth at 9.90%
Solid earnings growth at 18.00%
Decent profitability, keeps $12 per $100 revenue
Supporting Valuation Data
Cognex Corporation (CGNX) Detailed Analysis Report
Overall Assessment
This company scores 45/100 in our Smart Analysis, earning a D grade. Out of 10 metrics analyzed, 2 register as strengths (avg 8.5/10) while 8 fall into concern territory (avg 3.9/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap.
The Bear Case
The primary concerns are Price/Sales, Price/Book, Return on Equity. Some valuation metrics including PEG Ratio (2.71), Price/Sales (8.57), Price/Book (5.51) suggest expensive pricing. Growth concerns include Revenue Growth at 9.90%, EPS Growth at 18.00%, which may limit upside. Profitability pressure is visible in Return on Equity at 7.61%, Operating Margin at 14.00%, Profit Margin at 11.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Price/Sales improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 7.61% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 9.90% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Price/Sales and Price/Book are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CGNX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CGNX's Price-to-Sales ratio of 8.57x trades 49% below its historical average of 16.92x (5th percentile). The current valuation is 76% below its historical high of 36.34x set in Nov 2017, and 14% above its historical low of 7.52x in Feb 2009.
Compare CGNX with Competitors
Top SCIENTIFIC & TECHNICAL INSTRUMENTS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Cognex Corporation (CGNX) · TECHNOLOGY › SCIENTIFIC & TECHNICAL INSTRUMENTS
The Big Picture
Cognex Corporation operates as a stable business with moderate growth and solid fundamentals. Revenue reached 994M with 10% growth year-over-year. Profit margins of 11.5% are healthy, with room for further expansion as the business scales.
Key Findings
Generating 72M in free cash flow and 75M in operating cash flow. Earnings are translating into actual cash generation.
Debt-to-equity ratio of 0.05 indicates a conservative balance sheet with 263M in cash.
What to Watch Next
Margin expansion: can Cognex Corporation push profit margins above 15% as the business scales?
Valuation compression risk at a P/E of 75.0x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive moves, and regulatory changes that could impact Cognex Corporation.
Bottom Line
Cognex Corporation offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Cognex Corporation(CGNX)
NASDAQ
TECHNOLOGY
SCIENTIFIC & TECHNICAL INSTRUM...
USA
Cognex Corporation offers machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks globally. The company is headquartered in Natick, Massachusetts.